CardioComm Solutions, Inc.
EKGGFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$908878
P/E Ratio—
52W High$0.011
52W Low$0.003
CardioComm Solutions, Inc. (EKGGF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
EKGGF · earnings · updated Jun 15, 2026
Latest Earnings
Q4 FY2025Report Date: Dec 1, 2025EPS Actual
-$0.00
Revenue
$0.00B
Fiscal Period
Q4 FY2025
FY ends December
Report Date
Dec 1, 2025
After Market Close
EKGGF reports quarterly as a OTC-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
79
days
Expected Date
Sep 2, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away79
Expected DateSep 2, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Jun 15, 2026 | — | — | — | — | — | — |
| — Q4 FY2025 | Dec 1, 2025 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2025 | Aug 27, 2025 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2025 | May 29, 2025 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2025 | Apr 30, 2025 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2024 | Nov 27, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2024 | Aug 29, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2024 | May 30, 2024 | — | -$0.00 | — | $0.00B | — | — |
Q2 FY2026
Jun 15, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2025
Dec 1, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2025
Aug 27, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
May 29, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
Apr 30, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Nov 27, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2024
Aug 29, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
May 30, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
No analyst estimates available for EKGGF.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2025 | Dec 1, 2025 | — | $0.01 | $0.01 | +0.00% |
| — Q3 FY2025 | Aug 27, 2025 | — | $0.00 | $0.00 | +0.00% |
| — Q2 FY2025 | May 29, 2025 | — | $0.01 | $0.01 | +0.00% |
| — Q2 FY2025 | Apr 30, 2025 | — | $0.01 | $0.01 | +0.00% |
| — Q4 FY2024 | Nov 27, 2024 | — | $0.01 | $0.01 | +0.00% |
| — Q3 FY2024 | Aug 29, 2024 | — | $0.01 | $0.01 | +0.00% |
| — Q2 FY2024 | May 30, 2024 | — | $0.00 | $0.01 | +175.00% |
| — Q1 FY2024 | Mar 30, 2024 | — | No price data | $0.00 | — |
Q4 FY2025+0.00%
Report Date
Dec 1, 2025
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2025+0.00%
Report Date
Aug 27, 2025
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q2 FY2025+0.00%
Report Date
May 29, 2025
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q2 FY2025+0.00%
Report Date
Apr 30, 2025
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q4 FY2024+0.00%
Report Date
Nov 27, 2024
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2024+0.00%
Report Date
Aug 29, 2024
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q2 FY2024+175.00%
Report Date
May 30, 2024
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.01
Q1 FY2024—
Report Date
Mar 30, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$0.00
Beat Rate0 / 8 quarters
Largest Move+175.00% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: EKGGF ends December
CardioComm Solutions, Inc. (EKGGF) most recently reported earnings on December 1, 2025 for Q4 FY2025, posting EPS of $-0.00 (in line with the analyst consensus of —). The next EKGGF earnings date is expected around September 2, 2026.
Each quarter, investors track EKGGF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EKGGF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
EKGGF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
EKGGF earnings · 4 questionsCardioComm Solutions, Inc.'s next earnings report is expected around September 2, 2026. EKGGF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EKGGF historically reports after market close (AMC).
EKGGF earnings datewhen is EKGGF earningsEKGGF next earnings datewhen does EKGGF report earningsEKGGF earnings calendar
▸ Source: FMP · CardioComm Solutions, Inc. SEC filings · US GAAP · CardioComm Solutions, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026